EBITDA: Income before interest, taxes, depreciation and amortization.
PharmChem Inc. (PCHM) had EBITDA of $6.08M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$6.08M |
|
$1.38M |
|
-- |
|
$6.08M |
|
-- |
|
$6.08M |
|
-- |
|
$6.08M |
|
$6.08M |
|
$6.08M |
|
$1.38M |
|
$1.38M |
|
$6.08M |
|
$6.08M |
|
|
EBITDA |
$6.08M |
4.64M |
|
4.64M |
|
$0.30 |
|
$0.30 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
22.70% |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|